-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 VlMIs3WWc2NRbwpMf6K4szysDzqrNYX9hr0n8PkVNOmltiaBlTAz4t2SXN7J+cVN
 jSf7PJu0sTLW0HrupKG+HQ==

<SEC-DOCUMENT>9999999997-02-053732.txt : 20021008
<SEC-HEADER>9999999997-02-053732.hdr.sgml : 20021008
<ACCEPTANCE-DATETIME>20021008152120
<PAPER>
ACCESSION NUMBER:		9999999997-02-053732
CONFORMED SUBMISSION TYPE:	REGDEX
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		
FILED AS OF DATE:		20021004
EFFECTIVENESS DATE:		20021004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KADMUS PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001163571

	FILING VALUES:
		FORM TYPE:		REGDEX
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	021-48380
		FILM NUMBER:		02059970

	MAIL ADDRESS:	
		STREET 1:		2730 SAND HILL RD STE 200
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
</SEC-HEADER>
<DOCUMENT>
<TYPE>REGDEX
<SEQUENCE>1
<FILENAME>9999999997-02-053732.paper
<DESCRIPTION>AUTO-GENERATED PAPER DOCUMENT
<TEXT>
This document was generated as part of a paper submission.
Please reference the Document Control Number 02059970 for access to the original document.
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----